Security key
04390B105
ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG)
CUSIP: 04390B105
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 81,771
- Total 13F value
- $3,219,883
- Share change
- -155,423
- SEC-reported price per share
- $39.38
- Number of holders
- 11
- Value change
- -$2,881,943
- Number of buys
- 9
- Number of sells
- 5
Report period
Q2 2025
Institutions
11
Top holders
10
AAPG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ASCENTAGE PHARMA GROUP INTERNATIONAL SEC filings
ASCENTAGE PHARMA GROUP INTERNATIONAL company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04390B105
Recent filing periods:
Ownership snapshot
Top reported holders of AAPG - ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Monashee Investment Manag...
Disclosed value leader
Monashee Investment Manag...
Comparable rows
0/6
Latest evidence
31 Mar 2025
13F
Highest disclosed value: $3,510,727
6 rows are not safely comparable across share classes.
Quick read
Monashee Investment Management LLC has the largest disclosed position value at $3.51M.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Monashee Investment Management LLC's linked filing trail.
Disclosed position value
Top 5
Monashee Investment Management LLC
$3.51M
Point72 (DIFC) Ltd
$557.6K
XY Capital Ltd
$515.9K
VOLORIDGE INVESTMENT MANAGEMENT, LLC
$349.9K
Verition Fund Management LLC
$217.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Monashee Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$3,510,727
159,942 shares
|
— | 31 Mar 2025 |
| Point72 (DIFC) Ltd |
13F
Company
|
—
denominator unverified
|
$557,618
25,404 shares
|
— | 31 Mar 2025 |
| XY Capital Ltd |
13F
Company
|
—
denominator unverified
|
$515,935
23,505 shares
|
— | 31 Mar 2025 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$349,949
15,943 shares
|
— | 31 Mar 2025 |
| Verition Fund Management LLC |
13F
Company
|
—
denominator unverified
|
$217,788
9,922 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$54,392
2,478 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
81,771
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q2 2026 Across Filers
Q2 2026 holders
7
Q2 2025 holders
11
Holder diff
4
| Investor | Q2 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend